Smart Pills Market are aligned with smart pills such as greater flexibility, precise delivery, real-time measurements, and monitoring of GI tract, and controlled operation or performance have acted as factors which can be employed to great advantage in drug development. They have several important applications, especially in diagnosis.
Market Research Future (MRFR’s) study on the global smart pills market indicates an impressive CAGR of 14.2% over the forecast period of 2018-2023. MRFR further asserts that the smart pills market is touted to reach USD 1,800 Mn by the end of 2023.
Avail Free Sample Copy Enabled with Detailed TOC at https://www.marketresearchfuture.com/sample_request/6591
Amidst cut-throat competition, reimbursement issues, and expiry of blockbuster patent drugs, there is immense pressure on the healthcare sector to innovate diagnosis solutions. This has provided fuel for the advancement and commercialization of the smart pill technology which has been there for decades.
Smart Pills Market Competitive Landscape
the notable players in the global smart pills market are,
- CapsoVision Inc.
- Proteus Digital Health Inc.
- JINSHAN Science & Technology
- MEDTRONIC
- Check-Cap
- BDD Limited
- Olympus Corporation
- PENTAX Medical
- FUJIFILM Holdings Corporation
- MEDISAFE
- INTROMEDIC
- and RF Co. Ltd.
With the surge in the occurrence of chronic diseases, especially gastrointestinal diseases, smart pills are increasingly emerging as an effective method of endoscopy. Lifestyle diseases such as gastroesophageal reflux disease (GERD), obesity, and gastric ulcers are on the rise due to rapid lifestyle changes and unhealthy eating habits. This has induced high demand for on-site diagnosis, and, in turn, drive the market for smart pills. Surging prevalence of colon cancer is a key factor which is motivating the growth of the smart pills market.
Smart pills have been a breakthrough in gastrointestinal tract diagnosis and are set to replace conventional methods of diagnosis such as colonoscopy and endoscopy. Capsule endoscopy has cropped up as an effective method to perform endoscopy which is non-invasive and causes very little discomfort. Increasing consumer preference for minimally invasive medical procedures is likely to induce greater demand within the smart pills market.
Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/smart-pills-market-6591
Segmentation
The global smart pills market has been segmented based on application, target area, disease indication, and end user.
By application, the smart pills market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further segmented into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The patient monitoring segment has been further segmented into capsule pH monitoring and others.
By target area, the smart pills market has been segmented into esophagus, small intestine, large intestine, and stomach.
By disease indication, the smart pills market has been segmented into esophageal diseases, small bowel diseases, colon diseases, and others.
By end user, the smart pills market has been segmented into hospitals, diagnostic center, and research institute.
Inquire for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/6591
Regional Analysis
By region, the smart pills market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
Conducive reimbursement scenario, the surging prevalence of chronic diseases, a nd fast uptake of advanced technology are the factors supporting the growth of the market in the region. The Americas account for the foremost share of the smart pills market.
Europe follows the Americas closely and accounts for the second most significant share of the smart pills market. Robust healthcare infrastructure, the high incidence rate of lifestyle-related diseases such as obesity, gastroesophageal reflux disease (GERD), and gastric ulcers have generated high demand for smart pills in the region. Moreover, European countries invest heavily in healthcare which acts as a plus for the growth of the market.
The APAC market is poised to perform relatively well and emerge as the fastest-growing market for smart pills. Percolation of advanced healthcare technologies in the region coupled with high healthcare expenditure in the developing countries of the region favors the growth of the market. Besides, increase in geriatric population and prevalence of various chronic diseases contribute to the growth of the market.
The minimum share of the smart pills market is held by MEA. Lack of knowledge, low healthcare penetration, and poor economic conditions, especially in the African region is hindering the growth of the market.
Ask for an Expert at https://www.marketresearchfuture.com/enquiry/6591
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/smart-pills-market-6591